Citalopram-induced hypophagia is enhanced by blockade of 5-HT(1A) receptors: Role of 5-HT(2C) receptors

British Journal of Pharmacology

Volumn 124, Issue 8, 1998, Pages 1781-1787

  Grignaschi, G ^a   Invernizzi, R W ^a   Fanelli, E ^a   Fracasso, C ^a   Caccia, S ^a   Samanin, R ^a  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

Author keywords

5 HT(1A) receptors; 5 HT(2C) receptors; 5 hydroxytryptaminne; Citalopram; Drugs' brain concentrations; Food intake; SB206553; SSRIs; WAY100635

Indexed keywords

CITALOPRAM; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; SEROTONIN 1A RECEPTOR; SEROTONIN 2C RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DORSAL RAPHE NUCLEUS; DRUG BRAIN LEVEL; DRUG POTENTIATION; FEEDING; FOOD INTAKE; HYPOPHAGIA; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR BLOCKING;

ANIMALS; CITALOPRAM; DOSE-RESPONSE RELATIONSHIP, DRUG; EATING; INJECTIONS; MALE; PIPERAZINES; PYRIDINES; RAPHE NUCLEI; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, SEROTONIN, 5-HT2C; RECEPTORS, SEROTONIN; RECEPTORS, SEROTONIN, 5-HT1; SEROTONIN AGONISTS; SEROTONIN ANTAGONISTS; SEROTONIN UPTAKE INHIBITORS;

EID: 0031870024     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0702028     Document Type: Article

References (44)

1. 1A receptor antagonists on hippocampal 5-hydroxytryptamine levels: (S)-WAY100135, but not WAY100635, has partial agonist properties. Eur. J. Pharmacol., 304, 15-21.
2. BEL, N. & ARTIGAS, F. (1992). Fluvoxamine preferentially increases extracellular 5-hydroxytryptamine in the raphe nuclei: an in vivo microdialysis study. Eur. J. Pharmacol., 229, 101-103.
3. 1A antagonist pindolol. In: Monitoring Molecules in Neuroscience, ed. Louilot, A., Durkin, T., Spampinato, U. & Cador, M. pp 209-210. Gradignan: Publi Typ.
4. BENDOTTI, C. & SAMANIN, R. (1986). 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT) elicits eating in free-feeding rats by acting on central serotonin neurons. Eur. J. Pharmacol., 121, 147-150.
5. 1A receptors. Eur. J. Pharmacol., 336, 1-6.
6. CARBONI, E. & DI CHIARA, G. (1989). Serotonin release estimated by transcortical dialysis in freely-moving rats. Neuroscience, 32, 637-645.
7. 1A receptors does not modify the effect of fluoxetine or 5-hydroxytryptophan on ethanol and food intake in rats. Psychopharmacology, 134, 55-63.
8. DOURISH, C.T., HUTSON, P.H., KENNETT, G.A. & CURZON, G. (1986). 8-OH-DPAT induced hyperphagia: its neuronal basis and possible therapeutic relevance. Appetite, 7, 127-140.
9. 1A receptor antagonist activity of WAY-100135 and spiperone. J. Pharmacol. Exp. Ther., 268, 441-447.
10. 2B receptor antagonist with improved affinity, selectivity, and oral activity. J. Med. Chem., 38, 2524-2530.
11. FORNAL, C.A., METZLER, C.W., VEASEY, S.C., McCREARY, A.C., DOURISH, C.T. & JACOBS, B.L. (1994). Single-unit recordings from freely-moving animals provide evidence that WAY-100635, but not (S)-WAY-100135, blocks the action of endogenous serotonin at the 5-HT autoreceptor. Br. J. Pharmacol., 112, 92P.
12. FULLER, R.W. (1994) Uptake inhibitors increase extracellular serotonin concentration measured by brain microdialysis. Life Sci., 55, 163-167.
13. 1A receptor antagonist and an SSRI in vivo: effects on 5-HT cell firing and extracellular 5-HT. Br. J. Pharmacol., 115, 1064-1070.
14. GRIGNASCHI, G. & SAMANIN, R. (1992). Role of serotonin and catecholamines in brain in the feeding suppressant effect of fluoxetine. Neuropharmacology. 31, 445-449.
15. GRIGNASCHI, G. & SAMANIN, R. (1993). Role of serotonin receptors in the effect of sertraline on feeding behaviour. Psychopharmacology, 110, 203-208.
16. 7 receptor in rat brain. Br. J. Pharmacol., 117, 657-666.
17. 2B 2C receptors in mediating fenfluramine-induced anorexia in rats. Br. J. Pharmacol., 114, 373P.
18. 1A receptor antagonists with an SSRI in conditioned fear stress-induced freezing behavior. Pharmacol. Biochem. Behav., 58, 471-475.
19. 1A autoreceptor blockade potentiates the ability of the 5-HT reuptake inhibitor citalopram to increase nerve terminal output of 5-HT in vivo: a microdialysis study. J. Neurochem., 60, 776-779.
20. 1A receptors or β-adrenoceptors, restrain the citalopram-induced increase in extracellular 5-hydroxytryptamine in vivo. Eur. J. Pharmacol., 316, 43-47.
21. HOYER, D. (1988). Functional correlates of serotonin 5-HT 1 recognition sites. J. Receptor Res., 8, 59-81.
22. HYTTEL, J. (1977). Neurochemical characterization of a new potent and selective serotonin uptake inhibitor: Lu 10-171. Psychopharmacology, 51, 225-233.
23. INVERNIZZI, R., BELLI, S. & SAMANIN, R. (1991). An increase of extracellular serotonin in the dorsal raphe masks the effect of sertraline in the frontal cortex. In: Monitoring Molecules in Neuroscience, ed. Rollema, H., Westerink, B.H.C. & Drijfhout, W.J. pp 253-255. Groningen: University Centre for Pharmacy.
24. INVERNIZZI, R., BELLI, S. & SAMANIN, R. (1992). Citalopram's ability to increase the extracellular concentrations of serotonin in the dorsal raphe prevents the drug's effect in the frontal cortex. brain Res., 584, 322-324.
25. 1A receptors in the effects of acute and chronic fluoxetine on extracellular serotonin in the frontal cortex. Pharmacol. Biochem. Behav., 54, 143-147.
26. 1A receptor antagonists on citalopram-induced increase in extracellular serotonin in the frontal cortex, striatum and dorsal hippocampus. Neuropharmacology, 36, 467-473.
27. 1A receptors. Pharmacol. Res, 35 (suppl.), 23.
28. 2B 2C receptor antagonist. Br. J. Pharmacol., 111, 797-802.
29. 2B receptor antagonist, after chronic treatment. Br. J. Pharmacol., 114, 370P.
30. 2B receptor antagonist with anxiolytic-like properties. Br. J. Pharmacol., 117, 427-434.
31. 2B receptor agonist, causes hyperphagia and reduced grooming in rats. Neuropharmacology, 36, 233-239.
32. 2C receptor antagonist. Neuropharmacology, 36, 609-620.
33. 1A receptor ligands (+)-WAY 100 135 and SDZ 216-525. Eur. J. Pharmacol., 249, 25-35.
34. LIGHTOWLER, S., WOOD, M., BROWN, T., GLEN, A., BLACKBURN, T., TULLOCH, I. & KENNETT, G. (1996). An investigation of the mechanism responsible for fluoxetine-induced hypophagia in rats. Eur. J. Pharmacol., 296, 137-143.
35. LUCKI, I., KREIDER, M.S. & SIMANSKY, K.J. (1988). Reduction of feeding behavior by the serotonin uptake inhibitor sertraline. Psychopharmacology, 96, 289-295.
36. OYEHAUG, E., OSTENSEN, E.T. & SALVESEN, B. (1984). High-performance liquid chromatographic determination of citalopram and four of its metabolites in plasma and urine samples from psychiatric patients. J. Chromatogr., 308, 199-208.
37. PAXINOS, G. & WATSON, C. (1982). The Rat Brain in Stereotaxic Coordinates New York: Academic Press Inc.
38. PAZOS, A., HOYER, D., DIETL, M.M. & PALACIOS, J.M. (1988). Autoradiography of serotonin receptors. In Neuronal Serotonin. ed. Osborne, N.N. & Hamon, M. pp 507-543. Chichester: John Wiley.
39. 1A receptor antagonists in the dorsal raphe pathway: role of somatodendritic autoreceptors. J. Neurochem., 68, 2593-2603.
40. SAMANIN, R. & GRIGNASCHI, G. (1996). Role of 5-hydroxytryptamine receptor subtypes in satiety and animal models of eating disorders. In Drug receptor subtypes and ingestive behaviour. ed. Cooper, S.J. & Clifton, P.J. pp 39-58. London: Academic Press.
41. 1A receptor antagonists and selective 5-HT reuptake inhibitors in isolated aggressive mice. Eur. J. Pharmacol., 334, 127-132.
42. 2C serotonin receptors. Nature, 374, 542-546.
43. 1A autoreceptor blockade in rats: in vivo microdialysis and behavioural studies. Br. J. Pharmacol., 122, 298P.
44. YEN, T.T., WONG, D.T. & BEMIS, K.G. (1987). Reduction of food consumption and body weight of normal and obese mice by chronic treatment with fluoxetine: a serotonin re-uptake inhibitor. Drug Dev. Res., 10, 37-45.